NCT07304167

Brief Summary

The goal of this clinical trial is to compare the effects of an exergame-based exercise program and a home-based exercise program in women aged 30-70 years diagnosed with fibromyalgia (FM). The main questions it aims to answer are: Does an exergame-based program using the Nintendo Switch game Ring Fit Adventure improve pain, balance, and functional mobility in women with fibromyalgia? Is the exergame program more effective than a traditional home-based exercise program in improving physical and psychosocial outcomes? Researchers will compare the exergame group and the home-based exercise group to determine whether game-based exercises provide superior benefits in pain reduction, balance, and quality of life. Participants will: Be randomly assigned to either the exergame or the home-based exercise group. Exercise twice a week for four weeks under the supervision of a physiotherapist or via remote monitoring. Undergo evaluations before and after the 4-week training period, and again after a 4-week detraining period. Assessments will include: Pain intensity (Visual Analog Scale) Disease severity (Revised Fibromyalgia Impact Questionnaire, Widespread Pain Index, Symptom Severity Scale, Fibromyalgia Severity Scale) Lower extremity strength (Sit-to-Stand Test) Functional mobility (Timed Up and Go Test) Balance (Single-Leg Stance Test, Berg Balance Scale) Psychosocial status (Cognitive Exercise Therapy Approach Questionnaire - BETY-BQ) Quality of life (Short Form-12) Study findings are expected to provide evidence for the effectiveness of exergame applications as an enjoyable rehabilitation approach for individuals with fibromyalgia.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 26, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2026

Completed
Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

December 12, 2025

Last Update Submit

January 8, 2026

Conditions

Keywords

FibromyalgiaExergamingExerciseRehabilitation

Outcome Measures

Primary Outcomes (2)

  • Revised Fibromyalgia Impact Questionnaire

    The Revised Fibromyalgia Impact Questionnaire will be used to assess the impact of fibromyalgia (FM) on patients. The questionnaire consists of 21 items. All items are based on an 11-point numerical rating scale ranging from 0 to 10, where 10 indicates the worst possible condition. It comprises three domains: function, overall impact, and symptoms. The total score for the function domain (range 0-90) is divided by 3; the overall impact domain (range 0-20) is left unchanged; and the total score for the symptom domain (range 0-100) is divided by 2. The overall Revised Fibromyalgia Impact Questionnaire score is the sum of these three domain scores.

    Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up

  • Fibromyalgia Severity Scale

    The Fibromyalgia Severity Scale is calculated by summing the scores of the Widespread Pain Index (WPI) and the Symptom Severity Scale (SSS). The maximum total score is 31 (19 + 12 = 31). A total score below 12 is generally not considered indicative of fibromyalgia.

    Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up

Secondary Outcomes (7)

  • Visual Analog Scale (VAS)

    Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up

  • 30-Second Sit-to-Stand Test

    Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up

  • Timed Up and Go Test

    Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up

  • Single-Leg Stance Test

    Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up

  • Berg Balance Scale

    Assessed at baseline, post-intervention (4 weeks), and at 8-week follow-up

  • +2 more secondary outcomes

Study Arms (2)

Exergame group

EXPERIMENTAL

Participants in this group will perform exergame-based exercises.

Other: Exergaming

Home-based exercise group

EXPERIMENTAL

Participants in this group will perform home-based exercise sessions.

Other: Home-based exercise

Interventions

Participants in the exergame group will perform exercises using the Nintendo Switch game Ring Fit Adventure under the supervision of a physiotherapist, twice a week for four weeks. The exergame program was designed by a specialist physiotherapist.

Exergame group

Participants in the home-based exercise group will perform exercises prescribed by a specialist physiotherapist as a home program, twice a week for four weeks. The exercises will be taught to participants in face-to-face sessions. Once a week, participants in the home-based exercise group will meet via Zoom to monitor exercise accuracy and progression. The home-based exercise program was adapted from the study conducted by Gentile et al. (2024).

Home-based exercise group

Eligibility Criteria

Age30 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged between 30 and 70 years, which is an age range in which fibromyalgia (FM) is more prevalent;
  • Having a diagnosis of fibromyalgia;
  • Being willing to participate in the study and signing the informed consent form;
  • Meeting the 2016 American College of Rheumatology (ACR) diagnostic criteria, defined as a Widespread Pain Index (WPI) ≥ 7 and a Symptom Severity Scale (SSS) score ≥ 5, or WPI = 4-6 and SSS ≥ 9.

You may not qualify if:

  • Pregnancy or breastfeeding
  • Any known advanced pathology related to the locomotor system that contraindicates physical activity (such as arthritis, osteoarthritis, or uric acid disorders)
  • Epilepsy
  • History of severe headache
  • Neurological disorder
  • Peripheral neuropathy
  • Known severe cardiovascular disease (such as endocranial hypertension, uncontrolled arterial hypertension, heart failure, or presence of a pacemaker)
  • Orthopedic disorders of the upper or lower extremities that prevent participation in physical activity
  • Rheumatologic disease other than fibromyalgia
  • Pneumothorax
  • Neoplasia
  • Surgery within the last four months
  • Severe psychiatric illness (such as uncontrolled depression and anxiety, personality disorders, dementia, or cognitive impairments related to substance abuse)
  • Diagnosis of alcohol dependence or use of psychoactive drugs or narcotics
  • Participation in any physical activity program within two months prior to the start of the study
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Halic University

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

FibromyalgiaMotor Activity

Interventions

Exergaming

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesBehavior

Intervention Hierarchy (Ancestors)

ExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Gülhan Fetin, PT

    Halic University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ayşenur Çetinkaya, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, PhD

Study Record Dates

First Submitted

December 12, 2025

First Posted

December 26, 2025

Study Start

December 15, 2025

Primary Completion

February 28, 2026

Study Completion

March 5, 2026

Last Updated

January 9, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations